SCHEMBL25002912

SCHEMBL25002912

CCCOc1ccc(-c2nccc(C(=O)OC)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 2/20 0.48
▸ MAPT P10636 5/20 0.48
▸ PLK1 P53350 1/20 0.47
▸ ACACB O00763 2/20 0.47
▸ RAB9A P51151 4/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ALPL P05186 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ S1PR1 P21453 1/20 0.45
▸ S1PR3 Q99500 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ ACACA Q13085 1/20 0.44
▸ XDH P47989 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002892 0.95 NPC1 (0.52) PLA2G2AMAPTRAB9AKMT2AALDH1A1
SCHEMBL25002930 0.89 RAB9A (0.49) MAPTPLK1ACACBRAB9AKMT2A
SCHEMBL25003794 0.86 PLK1 (0.49) MAPTPLK1ACACBRAB9AKMT2A
SCHEMBL25002922 0.85 KMT2A (0.56) MAPTKMT2AALDH1A1NPC1KDM4E
SCHEMBL25003134 0.81 NPC1 (0.51) MAPTRAB9AKMT2AALDH1A1NPC1
SCHEMBL25002901 0.80 ADORA3 (0.49) MAPTRAB9AKMT2ANPC1SMN1; SMN2
SCHEMBL25002900 0.80 KMT2A (0.51) MAPTACACBRAB9AKMT2AALDH1A1
SCHEMBL25002890 0.79 MAP4K4 (0.51) MAPTRAB9AKMT2AALDH1A1NPC1
SCHEMBL22027749 0.79 KMT2A (0.42) MAPTRAB9AKMT2AALDH1A1NPC1
SCHEMBL25002917 0.79 PLA2G2A (0.54) PLA2G2AMAPTRAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback